Tamoxifen for carcinoma, intraductal, noninfiltrating

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Nov 2008: Trial started, NCT01357772
  2. 23 May 2011: Trial registered, NCT01357772

The trials

NCT01357772: Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

State
Under way
Phase
Phase 3
People
500 taking part
Started
12 Nov 2008
Primary completion
31 Dec 2022
Arms
Tamoxifen
Results
None posted
  1. 12 Nov 2008: Trial started
  2. 23 May 2011: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Mammaton, Novaldex, Tamoplex.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.